Burstein SH |
The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. |
1999 |
Pharmacol. Ther. |
pmid:10341359
|
Williams CM and Kirkham TC |
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. |
1999 |
Psychopharmacology (Berl.) |
pmid:10353436
|
Fimiani C et al. |
Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. |
1999 |
Cell. Signal. |
pmid:10353693
|
Ng EW et al. |
Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. |
1999 |
J. Med. Chem. |
pmid:10354405
|
Gebremedhin D et al. |
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. |
1999 |
Am. J. Physiol. |
pmid:10362691
|
Ameri A et al. |
Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. |
1999 |
Br. J. Pharmacol. |
pmid:10372827
|
De Petrocellis L et al. |
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. |
1999 |
Neuroscience |
pmid:10392859
|
Zenor BN et al. |
Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves. |
1999 |
Life Sci. |
pmid:10416818
|
Di Marzo V et al. |
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. |
1999 |
Lipids |
pmid:10419192
|
Hansen HS et al. |
Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. |
1999 |
Lipids |
pmid:10419193
|
Ueda N et al. |
An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. |
1999 |
FEBS Lett. |
pmid:10431820
|
Zygmunt PM et al. |
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. |
1999 |
Nature |
pmid:10440374
|
González S et al. |
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. |
1999 |
Life Sci. |
pmid:10447218
|
Melck D et al. |
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10448105
|
Martin BR et al. |
Discovery and characterization of endogenous cannabinoids. |
1999 |
Life Sci. |
pmid:10462059
|
Khanolkar AD and Makriyannis A |
Structure-activity relationships of anandamide, an endogenous cannabinoid ligand. |
1999 |
Life Sci. |
pmid:10462061
|
Howlett AC et al. |
Signal transduction of eicosanoid CB1 receptor ligands. |
1999 |
Life Sci. |
pmid:10462062
|
Di Marzo V |
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. |
1999 |
Life Sci. |
pmid:10462065
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. |
1999 |
Curr. Med. Chem. |
pmid:10469888
|
Molderings GJ et al. |
Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10494885
|